Drug Manufacture InnoCare’s Tafasitamab Combo for Blood Cancer ApprovedBy MohamedMis2July 17, 2023 InnoCare Pharmaceuticals Ltd. achieves a significant milestone as the Hong Kong Department of Health approves the use of tafasitamab. This…
